Merck KGaA to acquire Bio-Techne (TECH) for <meta name=

7B Sigma-Aldrich buy in 2014, marking a return to mega-deal life-sciences …" /> 1.3B EV at $73/share all-cash on Thursday June 25 — 36% premium to 1-month VWAP / +24% to $58.88 prior close; TECH +20.02% to $70.67 in Merck's biggest deal since 2014 Sigma-Aldrich, ~€140M run-rate synergies by year 3, close late-2026 / early-2027" /> 7B Sigma-Aldrich buy in 2014, marking a return to mega-deal life-sciences …" /> 1.3B EV at $73/share all-cash on Thursday June 25 — 36% premium to 1-month VWAP / +24% to $58.88 prior close; TECH +20.02% to $70.67 in Merck's biggest deal since 2014 Sigma-Aldrich, ~€140M run-rate synergies by year 3, close late-2026 / early-2027" /> 7B Sigma-Aldrich buy in 2014, marking a return to mega-deal life-sciences …" />

Stock/TLDR — What Just Moved Markets: Earnings, Fed, M&A, MoversA high-volume feed of market-moving releases — quarterly earnings, FOMC decisions, M&A, regulatory actions, big single-name moves, macro prints, commodities and crypto — refreshed every 12 hours. Each release is explained in plain English so you actually understand what just happened and which tickers it touches.This site uses JavaScript to render the interactive feed. Enable JavaScript to use it.Stock/TLDR is not investment advice. Verify everything against primary sources before trading.